Jazz Pharmaceuticals (JAZZ) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

JAZZ Jazz Pharmaceuticals

Watchlist

122.640
-0.150-0.12%

Close Nov 27 16:00 ET

126.820
+4.180+3.41%

Pre 06:06 ET

7.41BMarket Cap17.37P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Why Jazz Pharmaceuticals (JAZZ) Is One of the Most Undervalued Pot Stocks to Buy?
Yahoo FinanceNov 28 05:50 ET
RBC Capital Reaffirms Their Buy Rating on Jazz Pharmaceuticals (JAZZ)
TipRanksNov 27 20:48 ET · Ratings
Axsome Therapeutics' AXS-12 Data For Sleeping Disorder Boosts Confidence In Approval And Market Potential, Analyst Says
Analyst UpgradesNov 27 13:23 ET
Express News | Jazz Pharmaceuticals PLC - Revolving Credit Facility Maturity Date Extended to November 26, 2029
ReutersNov 26 17:10 ET
Express News | Jazz Pharmaceuticals PLC - Amends Credit Agreement to Increase Commitments
ReutersNov 26 17:10 ET
A Quick Look at Today's Ratings for Jazz Pharmaceuticals(JAZZ.US), With a Forecast Between $160 to $207
Moomoo NewsNov 22 08:00 ET · Ratings

Comments

Meltyy

Nov 26 01:17

🚨 1 PDUFA this week!

See FDA PDUFA update 👇
$Applied Therapeutics (APLT.US)$ : 🤔
⇨ Govorestat
‣ Classic Galactosemia
‣ PDUFA: 11/28/24 (NDA)
🗓️ Last Week’s Adcom & PDUFA decisions:
$BridgeBio Pharma (BBIO.US)$ : Approved 11/22 ✅
⇨Attruby (Acoramidis)
‣ ATTR-CM (transthyretin amyloid cardiomyopathy)
‣ PDUFA: 11/29/24 (NDA)
$AstraZeneca (AZN.US)$ : Discussion, no vote
⇨ Andexxa (coagulation factor Xa)
‣ Life-threatening or uncontrolled bleeding
‣ Adcom: 11/21/24 (sBLA)
$Jazz Pharmaceuticals (JAZZ.US)$ & $Zymeworks (ZYME.US)$ : Approve...

Stock_Drift

Nov 20 18:32

$Jazz Pharmaceuticals (JAZZ.US)$

10xStockPicks

Oct 24 07:55

Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable

Esperion $Esperion Therapeutics (ESPR.US)$ We reiterate Strong Buy rating. Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 million Americans take statin drugs, we see continued prescription growth & expect over 5...